Newsletter
Newsletter
Multivitamins delay HIV progression and death
July 01, 2004 | ||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Life Extension Update Exclusive Multivitamins delay HIV progression and death The trial enrolled 1078 HIV positive pregnant women in Tanzania starting in 1995 and followed them until August 2003. The women were administered 5000 units vitamin A plus 30 milligrams beta carotene per day, a multivitamin regimen consisting of B complex with 500 milligrams vitamin C and 30 milligrams vitamin E, both regimens combined, or a placebo. All participants received prenatal folic acid and iron supplements. The women were examined monthly throughout the follow-up period. Blood samples taken at the beginning of the study and every six months were analyzed for T-cell subgroup levels. At the study’s conclusion, 31.1 percent of the placebo group experienced disease progression compared to 24.7 of those who received the multivitamin regimen. Additionally, the multivitamin regimen reduced the risk of mortality from the disease, improved T-cell CD4+ and CD8+ counts, and lowered viral loads significantly. The effects of vitamin A and beta-carotene alone did not differ significantly compared to the placebo, and reduced some of the benefits experienced by the multivitamin regimen when added to it. In an accompanying editorial, Barbara Marston MD and Kevin M DeCock MD recommend a larger trial of nutritional supplements in African patients with HIV to confirm these results, yet write that “individual treatment programs and clinicians would be justified in routinely prescribing this nutritional support, since it may provide a benefit and does no harm.” | ||||||||||||||||||||||||||||||||||
Protocol HIV and AIDS Low levels of antioxidants and micronutrients in AIDS are most often related to low intake, as well as to malabsorption resulting from diarrhea, and also to metabolic problems and AIDS wasting. There are causes of immune suppression that have been proven to create a malabsorption syndrome in the gastrointestional tract (e.g., diarrhea, metabolic conditions, AIDS wasting, and drug therapies) (see also the section on Other Causes of Immune Suppression). Malabsorption syndrome is a significant component in the vicious cycle of immune suppression because it can be considered to be both a cause and an effect of immune suppression. Therefore not being able to utilize ingested foods and nutrients can be a specific cause of malnutrition in immune-suppressed patients. It is essential to break the cycle of malabsorption, antioxidant depletion, oxidative stress, immunosuppression, and the resulting increase in malabsorption. It is helpful to remember that the majority of immune system components and their activity is located in the gastrointestinal tract. Immune system activity has a particularly dominant influence in the mucosal lining since the mucosal lining is the area of the body that must assimilate material entering the gastrointestinal tract from the environment. In addition to its important role in the mediation of oxidative stress and free-radical damage, the amino acid glutamine also plays a major role in the overall health and well-being of the gastrointestinal tract and its supportive organs (stomach, small and large intestine, liver, pancreas, and gall bladder). Glutamine is vital to the function of intestinal cells called enterocytes. Enterocytes are located in the fingerlike projections of the mucosal villi. These cells make up the mucosal lining of the small intestines and are some of the most rapidly dividing cells in the body. They have high energy requirements. Glutamine is the primary nutrient for enterocytes. Enterocyte cells break down glutamine to form glutamate, which is then converted to ATP and used as the energy supply for the cells. Studies have confirmed that glucose (sugar) is not utilized as a fuel source for the intestine (Newsholme et al. 1985; Souba et al. 1985; Hartmann et al. 1989; Alverdy 1990). Lactoferrin is a subfraction of whey protein that has been found to both directly and indirectly inhibit several viruses that cause disease in humans. It directly inhibits viruses by binding to viral receptor sites, thus preventing the virus from infecting healthy cells. In vitro studies have found that lactoferrin strongly binds to the V3 loop of the gp120 receptor on HIV-1 and HIV-2, resulting in inhibition of virus-cell fusion and entry of the virus into cells (Swart et al. 1998). In addition, lactoferrin indirectly kills or inhibits viruses by augmenting the systemic immune response to a viral invasion. It is interesting to note that there is a systemic deficiency of lactoferrin in persons with HIV. One study that examined 22 asymptomatic and 45 symptomatic patients with HIV compared to 30 healthy controls found that "levels of plasma lactoferrin are decreased in HIV-1 infected patients in relation to the progression of the disease" (Defer et al. 1995). Another study found that the lack of lactoferrin (and secretory Iga) found in the oral cavities of people with HIV correlated strongly with the frequent infections in those areas often seen in patients with AIDS (Muller et al. 1992). Lactoferrin was also found to have "potent" antiviral effects against the replication of both human HIV and cytomegalovirus (CMV) in several in vitro studies with no cytopathic effects on healthy cells. | ||||||||||||||||||||||||||||||||||
L-glutamine is a nonessential amino acid that supplies energy to the brain, maintains healthy glucose levels, reduces fatigue, improves exercise endurance, and contributes to growth hormone release.
A minor fraction of whey, lactoferrin appears to have a wide variety of uses in biological systems and is considered a first line immune defense in the human body. Though a natural component of cow’s and human mother’s milk, lactoferrin is found throughout the human body. Published studies that have examined the use of lactoferrin as a supplement and its effects on immunity have been quite promising. First, lactoferrin helps to maintain a proper level of “good” bacteria in the intestinal tract, while controlling the number of “bad” bacteria, like E. coli and streptococcus. | ||||||||||||||||||||||||||||||||||
Life Extension Magazine July 2004 issue now online!
| ||||||||||||||||||||||||||||||||||
Questions? Comments? Send them to ddye@lifeextension.com or call 954 766 8433 extension 7716. Due to my vacation, Life Extension Update will not be published the week of July 5, and will resume publication July 12 2004. Have a safe and happy Independence day! For longer life, Dayna Dye Sign up for Life Extension Update at Subscribe Help spread the good news about living longer and healthier. Forward this email to a friend! View previous issues of Life Extension Update in the Newsletter Archive. |
Lab
Testing
How Life Extension lab testing works